$PHR Cashflow Statement | Understand Stock

$PHR

$12.50 -$0.11 (0.87%) Live

$PHR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jan 31, 2026	FY2025 12 months to Jan 31, 2025	FY2024 12 months to Jan 31, 2024	FY2023 12 months to Jan 31, 2023	FY2022 12 months to Jan 31, 2022
Operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
Stock-based compensation expense
Change in fair value of warrants liability
Amortization of deferred financing costs and debt discount
Loss on extinguishment of debt
Non-cash gain on settlement
Cost of Phreesia hardware purchased by customers
Deferred contract acquisition costs amortization
Non-cash operating lease expense
Change in fair value of contingent consideration liabilities
Deferred taxes
Gains and losses for fair value option

Changes in operating assets and liabilities:
Accounts receivable
Collections of principal on receivables originally held for sale to securitization
Accrued Interest Receivable
Prepaid expenses and other assets
Deferred contract acquisition costs
Accounts payable
Accrued expenses and other liabilities
Payment of due to provider for receivables originally held for sale to securitization
Lease liabilities
Deferred revenue
Net cash provided by (used in) operating activities
Investing activities:
Collections of cardholder receivables held for investment and deferred purchase price
Acquisitions, net of cash acquired
Capitalized internal-use software
Purchases of property and equipment
Net cash used in investing activities
Financing activities:
Proceeds from issuance of common stock in equity offerings, net of underwriters' discounts and commissions
Payment of preferred stock dividends
Proceeds from issuance of common stock upon exercise of stock options
Treasury stock to satisfy tax withholdings on stock compensation awards
Payment of offering costs
Proceeds from employee stock purchase plan
Insurance financing agreement
Finance lease payments
Constructive financing
Principal payments on financing agreements
Debt issuance costs
Loan facility fee payment
Debt issuance costs and loan facility fee payments
Financing payments of acquisition-related liabilities
Payments of revolving line of credit
Proceeds from term loan
Repayment of term loan and loan payable
Debt extinguishment costs
Proceeds from debt instruments
Principal payments on debt instruments
Payments due to provider for unfunded receivables
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net decrease in cash, cash equivalents and restricted cash
Cash and cash equivalents—beginning of year
Cash, cash equivalents and restricted cash—end of year
Supplemental information of non-cash investing and financing activities:
Non-cash activity related to credit card receivables and deferred purchase price
Right of use assets acquired in exchange for operating lease liabilities
Property and equipment acquisitions through finance leases
Purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities
Cashless transfer of term loan and related accrued fees into increase in debt balance
Cashless transfer of lender fees through increase in debt balance
Issuance of warrants related to debt
Receivables for cash in-transit on stock option exercises
Cashless exercise of common stock warrants
Capitalized stock-based compensation
Issuance of stock to settle liabilities for stock-based compensation
Deferred consideration liabilities payable in business combinations
Issuance of stock as consideration in business combinations
Capitalized software acquired through vendor financing

Cash paid for:
Interest
Income taxes

Comments